Summary
This 8-K filing from Agilent Technologies reports on the formal separation agreement with Nicolas Roelofs, former Senior Vice President and President of the Life Sciences Group. The agreement, effective November 7, 2013, outlines the terms of his departure, which was previously announced on September 19, 2013. Investors should note the financial implications of this separation, particularly the severance package and the treatment of Mr. Roelofs' equity awards.
Key Highlights
- 1Formal separation agreement executed with Nicolas Roelofs, former Senior Vice President and President, Life Sciences Group.
- 2Mr. Roelofs' termination date for program participation is October 31, 2013.
- 3Severance package includes a lump sum payment of $893,754 (19.5 months base pay) plus a standard severance of $206,246.
- 4Stock options, restricted stock units, and Long-Term Performance Program payments will be handled according to Agilent's Workforce Management Program.
- 5Mr. Roelofs has agreed to release Agilent from certain employment-related claims and adhere to post-employment restrictions, including confidentiality.
- 6This filing formalizes details previously announced in an 8-K on September 19, 2013.
- 7The full Separation Agreement is filed as an exhibit to this report.
Frequently Asked Questions
The main purpose of this filing is to provide the formal details of the separation agreement between Agilent Technologies and Nicolas Roelofs, former Senior Vice President and President of the Life Sciences Group, including the financial terms of his departure.
Mr. Roelofs will receive a lump sum severance payment of $893,754, representing 19.5 months of his base pay, in addition to a standard severance payment of $206,246. His equity awards (stock options, RSUs) and long-term performance payments will be treated in accordance with Agilent's Workforce Management Program.
Yes, Mr. Roelofs has agreed to release Agilent from certain claims related to his employment and to comply with post-employment restrictions, such as confidentiality obligations.
No, Agilent had previously announced that Mr. Roelofs would no longer serve in his executive roles in an 8-K filing on September 19, 2013. This filing provides the final details of his separation agreement.